Shenzhen Lifotronic Technology Co (688389) — Capital Reinvestment Ratio

Latest as of September 2025: 0.33x

Shenzhen Lifotronic Technology Co (688389) has a Capital Reinvestment Ratio of 0.33x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥53.10 Million) in capital expenditures (CN¥17.34 Million). See 688389 net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.33x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥53.10 Million
CNY

Capital Expenditures

CN¥17.34 Million
CNY

Data as of

Sep 2025
Most recent filing

Shenzhen Lifotronic Technology Co Capital Reinvestment Ratio (2016–2025)

This chart tracks Shenzhen Lifotronic Technology Co's Capital Reinvestment Ratio across 10 annual periods. Check Shenzhen Lifotronic Technology Co total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Shenzhen Lifotronic Technology Co (2016–2025)

Year-by-year Capital Reinvestment Ratio for Shenzhen Lifotronic Technology Co from 2016 to 2025. For live market cap and broader valuation context, see Shenzhen Lifotronic Technology Co (688389) total market value.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2025 0.30x CN¥280.97 Million CN¥83.44 Million ▲ +42.0%
2024 0.21x CN¥296.47 Million CN¥62.02 Million ▲ +30.7%
2023 0.16x CN¥303.82 Million CN¥48.62 Million ▼ -76.3%
2022 0.68x CN¥271.71 Million CN¥183.62 Million ▲ +1.2%
2021 0.67x CN¥182.07 Million CN¥121.57 Million ▲ +68.4%
2020 0.40x CN¥136.42 Million CN¥54.08 Million ▼ -45.9%
2019 0.73x CN¥91.82 Million CN¥67.33 Million ▼ -19.0%
2018 0.90x CN¥81.14 Million CN¥73.43 Million ▼ -73.3%
2017 3.39x CN¥35.25 Million CN¥119.45 Million ▲ +194.7%
2016 1.15x CN¥28.00 Million CN¥32.20 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow